Skip to main content
GLUE logo

GLUE · Monte Rosa Therapeutics, Inc.

Track GLUE — free
$13.84 -0.54 (-3.76%) At close · Sep 4
Market Cap
$1.21B
Shares
85.31M

Debt Profile

Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.

Coverage backlog: 32 eligible filings and 0 covenant artifacts have no current-version terminal extraction result. This includes untouched sources and sources on the retry ladder.
No terminal debt extraction result is available yet; this is not evidence that the company has no debt.
Key facts CIK 1826457 CUSIP 61225M102 13F (30d) 163 filings 162 filers Visit website Investor relations